Európska únia - slovenčina - EMA (European Medicines Agency)

novartis europharm limited - trametinib - melanóm - antineoplastické činidlá - melanomatrametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 a 5. trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior braf inhibitor therapy (see section 5. adjuvant treatment of melanomatrametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with stage iii melanoma with a braf v600 mutation, following complete resection. non-small cell lung cancer (nsclc)trametinib v kombinácii s dabrafenib je indikovaný na liečbu dospelých pacientov s pokročilým non-small cell lung cancer s braf v600 mutácie.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

shin-nippon commerce inc., chuo-ku, tokyo, japonsko (jp) japonsko -

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

technologie medicale 101 rue valliant couturier 93136 noisy-le-sec francúzsko -

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

corneal laboratoire 31, rue des colonnes du trône 750 12 paríž francúzsko -

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

b.braun petzold gmbh 34212 melsungen nemecko -

Európska únia - slovenčina - EMA (European Medicines Agency)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcíny - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

bioptimal international ltd. 36 jalan tukang 619 266 singapore singapur -

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

krka, d.d., novo mesto, slovinsko - teriflunomid - 59 - immunopraeparata